New Shingles Vaccine

A new, stronger shingles vaccine has been approved by the FDA, but it may not be suitable for everyone.

0
According to the CDC, Shingrix may be used in people with weakened immune systems. At this point, no studies have examined Shingrix in patients with autoimmune disease, cautions Dr. Calabrese. Shingrix includes a compound called an adjuvant that helps the vaccine create a stronger immune response. The adjuvant revs up the immune system, so there is a concern for exacerbating autoimmune diseases, explains Dr. Calabrese. Rheumatologists are awaiting further data on Shingrix in this patient population.
To continue reading this article or issue you must be a paid subscriber

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
| |

LEAVE A REPLY

Please enter your comment!
Please enter your name here